OPRX
OptimizeRx Corp

1,133
Mkt Cap
$284.64M
Volume
80,194.00
52W High
$22.25
52W Low
$3.99
PE Ratio
-5,873.08
OPRX Fundamentals
Price
$15.27
Prev Close
$15.38
Open
$15.51
50D MA
$18.07
Beta
1.56
Avg. Volume
270,116.61
EPS (Annual)
-$1.10
P/B
2.32
Rev/Employee
$714,162.79
Loading...
Loading...
News
all
press releases
Connor Clark & Lunn Investment Management Ltd. Makes New Investment in OptimizeRx Corp. $OPRX
Connor Clark & Lunn Investment Management Ltd. bought a new stake in OptimizeRx Corp. (NASDAQ:OPRX - Free Report) in the second quarter, according to its most recent filing with the Securities...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
P.A.W. Capital Corp Invests $675,000 in OptimizeRx Corp. $OPRX
P.A.W. Capital Corp purchased a new position in OptimizeRx Corp. (NASDAQ:OPRX - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and...
MarketBeat·9d ago
News Placeholder
New Strong Buy Stocks for Nov. 17: ROKU, AVPT, and More
ROKU, AVPT, ETOR, NRIM and OPRX have been added to the Zacks Rank #1 (Strong Buy) List on November 17, 2025.
Zacks·12d ago
News Placeholder
Los Angeles Capital Management LLC Makes New $349,000 Investment in OptimizeRx Corp. $OPRX
Los Angeles Capital Management LLC purchased a new stake in OptimizeRx Corp. (NASDAQ:OPRX - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The...
MarketBeat·12d ago
News Placeholder
OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·19d ago
News Placeholder
OptimizeRx (NASDAQ:OPRX) Issues Earnings Results, Beats Expectations By $0.17 EPS
OptimizeRx (NASDAQ:OPRX - Get Free Report) released its quarterly earnings results on Thursday. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.03 by $0.17...
MarketBeat·19d ago
News Placeholder
OptimizeRx (NASDAQ:OPRX) Raised to Strong-Buy at Wall Street Zen
Wall Street Zen upgraded OptimizeRx from a "buy" rating to a "strong-buy" rating in a research note on Saturday...
MarketBeat·20d ago
News Placeholder
OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Citizens Jmp Analyst Says
Citizens Jmp boosted their price objective on OptimizeRx from $23.00 to $24.00 and gave the stock a "market outperform" rating in a research note on Friday...
MarketBeat·21d ago
News Placeholder
OptimizeRx Corp. (OPRX) Tops Q3 Earnings and Revenue Estimates
OptimizeRx (OPRX) delivered earnings and revenue surprises of +566.67% and +11.25%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·23d ago
News Placeholder
OptimizeRx Corp. (OPRX) is a Great Momentum Stock: Should You Buy?
Does OptimizeRx Corp. (OPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks·2mo ago

Latest OPRX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.